Published in Drug Week, March 31st, 2006
"The aim of the present study was to investigate the effects of cannabinoid agonists on established inflammatory hyperalgesia. We have compared the effects of pre-administration versus post-administration of a potent non-selective cannabinoid agonist HU210 and a selective CB, receptor agonist JWH-133 on hindpaw weight bearing and paw edema in the carrageenan model of inflammatory hyperalgesia," researchers in England report.
S.J.R. Elmes and colleagues from the University of Nottingham explained, "For comparative purposes we also determined...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.